Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

Cited In for PubMed (Select 8648377)

1.

High expression of cytoplasmic phosphorylated CSE1L in malignant melanoma but not in benign nevi: phosphorylated CSE1L for the discrimination between melanoma and benign nevi.

Chin SY, Wu PR, Shih YH, Yeh CM, Lee WR, Shen SC, Yeh KT, Jiang MC, Tseng JT.

Int J Clin Exp Pathol. 2015 Feb 1;8(2):1393-401. eCollection 2015.

2.

Reliability and validity of mobile teledermatology in human immunodeficiency virus-positive patients in Botswana: a pilot study.

Azfar RS, Lee RA, Castelo-Soccio L, Greenberg MS, Bilker WB, Gelfand JM, Kovarik CL.

JAMA Dermatol. 2014 Jun;150(6):601-7. doi: 10.1001/jamadermatol.2013.7321.

3.

Learning reflectance confocal microscopy of melanocytic skin lesions through histopathologic transversal sections.

Braga JC, Macedo MP, Pinto C, Duprat J, Begnami MD, Pellacani G, Rezze GG.

PLoS One. 2013 Dec 5;8(12):e81205. doi: 10.1371/journal.pone.0081205. eCollection 2013.

4.

The MPATH-Dx reporting schema for melanocytic proliferations and melanoma.

Piepkorn MW, Barnhill RL, Elder DE, Knezevich SR, Carney PA, Reisch LM, Elmore JG.

J Am Acad Dermatol. 2014 Jan;70(1):131-41. doi: 10.1016/j.jaad.2013.07.027. Epub 2013 Oct 28.

5.

A case report - Volatile metabolomic signature of malignant melanoma using matching skin as a control.

Abaffy T, Möller M, Riemer DD, Milikowski C, Defazio RA.

J Cancer Sci Ther. 2011;3(6):140-144.

6.

Clinicopathologic features of incident and subsequent tumors in patients with multiple primary cutaneous melanomas.

Murali R, Goumas C, Kricker A, From L, Busam KJ, Begg CB, Dwyer T, Gruber SB, Kanetsky PA, Orlow I, Rosso S, Thomas NE, Berwick M, Scolyer RA, Armstrong BK; GEM Study Group.

Ann Surg Oncol. 2012 Mar;19(3):1024-33. doi: 10.1245/s10434-011-2058-8. Epub 2011 Sep 13. Erratum in: Ann Surg Oncol. 2013 Dec; 30 Suppl 3:S747-8.

7.

Assessment of copy number status of chromosomes 6 and 11 by FISH provides independent prognostic information in primary melanoma.

North JP, Vetto JT, Murali R, White KP, White CR Jr, Bastian BC.

Am J Surg Pathol. 2011 Aug;35(8):1146-50. doi: 10.1097/PAS.0b013e318222a634.

8.

The influence of clinical information in the histopathologic diagnosis of melanocytic skin neoplasms.

Ferrara G, Argenyi Z, Argenziano G, Cerio R, Cerroni L, Di Blasi A, Feudale EA, Giorgio CM, Massone C, Nappi O, Tomasini C, Urso C, Zalaudek I, Kittler H, Soyer HP.

PLoS One. 2009;4(4):e5375. doi: 10.1371/journal.pone.0005375. Epub 2009 Apr 30. Erratum in: PLoS One. 2009;4(6). doi: 10.1371/annotation/512cb17b-934c-4a06-9dbb-114d43052a2b.

9.

A multi-marker assay to distinguish malignant melanomas from benign nevi.

Kashani-Sabet M, Rangel J, Torabian S, Nosrati M, Simko J, Jablons DM, Moore DH, Haqq C, Miller JR 3rd, Sagebiel RW.

Proc Natl Acad Sci U S A. 2009 Apr 14;106(15):6268-72. doi: 10.1073/pnas.0901185106. Epub 2009 Mar 30.

10.

Interobserver reproducibility of histological features in cutaneous malignant melanoma.

Urso C, Rongioletti F, Innocenzi D, Saieva C, Batolo D, Chimenti S, Filotico R, Gianotti R, Lentini M, Tomasini C, Rebora A, Pippione M.

J Clin Pathol. 2005 Nov;58(11):1194-8.

11.

Skin biopsy rates and incidence of melanoma: population based ecological study.

Welch HG, Woloshin S, Schwartz LM.

BMJ. 2005 Sep 3;331(7515):481. Epub 2005 Aug 4.

12.
13.

Progressive increase in telomerase activity from benign melanocytic conditions to malignant melanoma.

Ramirez RD, D'Atri S, Pagani E, Faraggiana T, Lacal PM, Taylor RS, Shay JW.

Neoplasia. 1999 Apr;1(1):42-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk